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Background: Zanthoxylum zanthoxyloides and Z. leprieurii fruits are commonly used in traditional system of
medicine for diarrhea, pain, wound healing, etc. in Cameroon, Africa. Z. leprieurii fruits have been chemically studied
for its bioactive compounds whereas the investigation on Z. zanthoxyloides fruits is lacking.
Results: After a detailed chemical analysis of the fruits of Z. leprieurii and Z. zanthoxyloides, a series of new
acridone alkaloids, namely, 3-hydroxy-1,5,6-trimethoxy-9-acridone (1), 1,6-dihydroxy-3-methoxy-9-acridone
(2), 3,4,5,7-tetrahydroxy-1-methoxy-10-methyl-9-acridone (3), 4-methoxyzanthacridone (8), 4-hydroxyzanthacridone (9),
4-hydroxyzanthacridone oxide (2,4’) (10) have been isolated. The known acridones which have been characterized are,
helebelicine A (4), 1-hydroxy-3-methoxy-10-methyl-9-acridone (5), 1,3-dihydroxy-4-methoxy-10-methyl-9-acridone (6)
and tegerrardin A (7). The in vitro antibacterial and cytotoxic screening of these acridones reveal that compound
3 has a moderate antibacterial activity (MIC 125 μg/mL) against Micrococcus luteus and Pseudomonas aeruginosa while
compound 1 shows a moderate cytotoxic effect (IC50 of 86 μM) against WRL-68 (liver cancer cell line). Furthermore, the
molecular modeling of these acridones predicted the structural basis for their mode of action and binding affinity for
aromatase, quinone reductase and WAAG, a glycosyltransferase involved in bacterial lipopolysaccharide synthesis.
Computational approaches, quantitative SAR and modeling studies predicted that acridones 1, 2, 3, 4, 9 and 10 were
the inhibitors of glycosyltransferase while 1, 8, 9 and 10, the inhibitors of aromatase.
Conclusions: A total of 10 acridones have been isolated out of which 6 are new (1, 2, 3, 8, 9 and 10). Alkaloids 8, 9
and 10, having novel tetracyclic acridone structure with new carbon skeleton, have now been named as
zanthacridone. The quantitative SAR and molecular modeling studies suggested that the compounds 1, 9 and 10 are
inhibitors of both aromatase and glycosyltransferase.
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1, R= Me, R5= R6= OMe, R1= R2= R3= R4= R7= H
2, R= R1= R3= R4= R5= R7= H, R2= Me, R6= OH
3, R= R4= Me, R1= R2= R6= H, R3= R5= R7= OH
4, R= R4= Me, R1= R2= R5= R6= R7= H, R3= OMe
5, R= R1= R3= R5= R6= R7= H, R2= R4= Me
6, R= R1= R2= R5= R6= R7= H, R3= OMe, R4= Me
7, R= R4= Me, R1= R2= R3= R5= R6= R7= H
8, R= H, R1= Me
8a, R= Ac, R1= Me
9, R= R1= H




















Figure 1 Structures of acridones 1- 10.
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The pantropical genus Zanthoxylum (Rutaceae) is rep-
resented by 35 species in Africa [1]. Among them,
Zanthoxylum zanthoxyloides (Lam.) Zepern. & Timler
and Zanthoxylum leprieurii Guill. et Perr are found in
Cameroon and are well reputed for their ethnomedicinal
properties. Z. zanthoxyloides, formerly known as Fagara
zanthoxyloides, a popular African medicinal plant, occurs
abundantly in savanna and dry forest vegetations whereas
Z. leprieurii, is a medium tree found in rain forests and
savanna woodland, from sea-level up to the altitude of
2000 m [1,2]. In Cameroon, the leaves, stems and roots of
these plants are used in the treatment of gonococci, urinary
infections and dysentery [3]. In addition, the fruit infusion
of Z. leprieurii is shown to relegate the symptoms of sickle
cell anemia [2]. The aqueous ethanolic extracts of the
leaves, roots and stem bark of Z. leprieurii have demon-
strated moderate antifungal activity while the chloroform
extract of the fruits showed moderate cytotoxicity with
the brine-shrimp assay [4,5]. Recent reports on the dried
fruits of Z. leprieurii from Cameroon described the isola-
tion of acridone alkaloids that exhibited antiplasmodial
activity and in vitro cytotoxicity [5,6]. Its roots and
stem bark have yielded alkaloids (benzophenanthridines,
acridone, aporphine), aliphatic amides and lignans [5,7,8].
Several studies on Z. zanthoxyloides have established its
broad spectrum of biological activities, including sickle cell
anemia [9-11]. The antisickling divanylloylquinic acids as
well as the antifungal and antioxidant isobutylamide and
benzophenanthridine alkaloids have been reported from
the roots [12-14]. From its fruits, the components of es-
sential oils were also characterized [15,16]. Besides the
studies on its essential oil, no work has been carried out
on the constituents of its non volatile extract. A recent
study has revealed that the alcoholic extract of the fruits
of this plant possessed in vitro cytotoxic activity against
MCF-7, without identifying any bioactive constituents
[17]. This prompted us to undertake a comparative
study on the chemical constituents of the fruits of Z.
zanthoxyloides and Z. leprieurii to identify their bio-
active compounds.
In continuation of our work on the chemistry of medi-
cinal and aromatic plants [18-22], we have investigated
the fruits of two Zanthoxylum species collected from
Cameroon, Africa and recently reported their bioactive
non-alkaloidal phytoconstituents [23,24]. In the present
paper, we describe the isolation and structure elucidation
of several new acridone alkaloids, some of them with
novel structures, from Z. zanthoxyloides and Z. leprieurii
exhibiting antibacterial and cytotoxic activities. In order
to explore the possible mechanism of these activities, we
have also performed quantitative SAR of these acridones
along with their molecular docking experiments to iden-
tify their putative biological targets.Results and discussion
Isolation and identification of acridones
From the MeOH extract of the fruits of Z. zanthoxyloides,
6 new acridone alkaloids viz., 3-hydroxy-1,5,6-trimethoxy-
9-acridone (1), 1,6-dihydroxy-3-methoxy-9-acridone (2),
3,4,5,7-tetrahydroxy-1-methoxy-10-methyl-9-acridone
(3), 4-methoxyzanthacridone (8), 4-hydroxyzanthacridone
(9), 4-hydroxyzanthacridone oxide (2,4’) (10) along
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1-hydroxy-3-methoxy-10-methyl-9-acridone (5), have
been isolated and identified (Figure 1). Compounds 8- 10
have a tetracyclic acridone carbon skeleton reported for
the first time from Zanthoxylum spp. This novel acridone
skeleton has, tentatively, been named as zanthacridone.
From Z. leprieuri also, the new compound, 3-hydroxy-
1,5,6-trimethoxy-9-acridone (1), was isolated along
with three known acridones, namely, helebelicine A (4),
1,3-dihydroxy-4-methoxy-10-methyl-9-acridone (6) and
tegerrardin A (7). All the compounds were Dragendorff
positive and yellowish orange in color. The structures of
the new compounds were elucidated mainly by UV, IR,
NMR and MS spectroscopy (Additional file 1) and by
comparison with the data already reported in the lit-
erature for acridone alkaloids [5,25-32].
Compound 1 in its UV spectrum showed bands at 220,
233, 252 and 320 nm while in IR the bands appeared at
3448, 2929, 1620 cm-1 which suggested the presence of an
acridone skeleton. Its molecular formula was determined
by HRMS as C16H15O5N with [M]
+ at m/z 301.0944. On
the basis of the molecular formula and the assumption
of an acridone skeleton through comparison with theTable 1 1H NMR spectral data for 1-3, 8-10 (300 MHz, in CDCl
Proton 1 2 3 8
2 7.01(d,3.0) 6.58(d,3.0) 6.12(s) -
4 7.55(d,3.0) 6.44(d,3.0) - -
5 - 7.39(d,3.0) - 7
6 - - 7.20(d,3.0) 7
7 7.21(d,8.0) 7.07(dd,8.0,3.0) - 7
8 7.99(d,8.0) 7.89(d,8.0) 7.82(d,3.0) 7
1-OMe 4.40(s) - 4.44(s) -
3-OMe - 3.93(s) - -
4-OMe - - - 3
5-OMe 4.10(s) - - -
6-OMe 4.01(s) - - -
N-Me - - 3.90(s) 3
2’-Me - - - 1
1
3’ - - - 2
3
4’ - - - 3
1-OH - 12.12 - 1
3-OH 9.02 - 9.05* -
4-OH - - 9.00* -
5-OH - - 9.32* -
6-OH - 8.90 - -
7-OH - - 8.92* -
*Assignments interchangeable.literature data for similar compounds [5], compound
1 must be a trimethoxy-hydroxy-acridone. In the
unsubstituted acridone, the signals of the peri-protons
H-1 and H-8 are found at δ 8.25, while the neighbors
of N-10 are found at approximately δ 7.5. It follows that
the doublet at δ 7.99 ppm belongs to H-8; the coupling
constant indicated a proton (H-7) in ortho-position. As the
signal of H-7 did not show further couplings, the positions
C-5 and C-6 must be oxygenated. It was further substanti-
ated as in the 1H1H COSY spectrum H-7 showed correl-
ation only with H-8 and in HMBC it showed correlation
with C-7-OMe at δ 61.9. Its 1H NMR spectrum (Table 1)
showed a downfield singlet at δ 9.02 for C-3-OH along
with two meta coupled doublets (J = 3.0 Hz) at δ 7.01
and 7.55 indicating that C-1 and C-3 were substituted.
The presence of three singlets at δ 4.40, 4.10 and 4.01
each of 3H in 1H NMR spectrum and δ 61.9, 59.3 and
57.5 in its 13C NMR spectrum indicated that it contained
3 OMe groups. The HMBC spectrum showed correla-
tions as reported earlier [5] for 1,3 oxygenated acridones
(Experimental). Its 13C NMR spectrum also exhibited four
CH signals at 113.5, 104.8, 118.3 and 162.3 along with four
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and C rings are oxidized at 4 positions having 3 methoxy
and a hydroxy functional group. The absence of the singlet
of a chelated hydroxyl group in the region of δ 10-15 in its
1H NMR spectrum indicated that the peri positions C-1
and C-8 were not hydroxylated. This was further reinforced
by the presence of the strongly downfielded signals at δ
4.40 in its 1H NMR spectrum and at δ 158.0 and 61.9 for
C-1-OMe in its 13C NMR spectrum. The meta coupled
doublets at δ 7.01 and 7.55 (J = 3.0 Hz) for H-2 and H-4
indicated that C-3 is also oxidized which was supported by
the typical signal for C-3 in acridones at δ 152.6 in its 13C
NMR spectrum. The C-3-OH signal at δ 9.02 correlated
with C-3 at δ 152.6 in its HMBC spectrum, clearly indicat-
ing the placement of phenol in A ring. The downfield signal
at δ 7.99 in 1H NMR spectrum which is typical for H-8
showed ortho coupling (J = 8.0 Hz) with H-7, correlation
in 1H1H COSY and no meta coupling, suggesting that
two other methoxy groups are present at C-5 and C-6.
The relatively strong upfield shifted C-4 signal at δ
104.8 in 13C NMR spectrum for aromatic carbon fitted
well with the earlier report [5]. The rest of the signals of
13C NMR spectrum, when compared with the literatureTable 2 13C NMR spectral data for 1-3, 8-10 (75 MHz, in
CDCl3, δ in ppm)
Carbon 1 2 3 8 9 10
1 158.0 (s) 161.2 (s) 160.0 (s) 162.1 (s) 160.0 (s) 159.3(s)
2 113.5 (d) 94.3 (d) 92.7 (d) 118.2 (s) 117.5 (s) 160.2 (s)
3 152.6 (s) 162.4 (s) 161.3 (s) 166.5 (s) 166.4 (s) 166.5 (s)
4 104.8 (d) 90.7 (d) 130.2 (s) 123.0 (s) 122.1 (s) 131.2 (s)
4a 143.3 (s) 140.7 (s) 141.2 (s) 139.3 (s) 139.0 (s) 124.8 (s)
5a 144.0 (s) 140.7 (s) 141.3 (s) 139.3 (s) 140.2 (s) 133.2 (s)
5 145.1 (s) 104.4 (d) 146.2 (s) 115.0 (d) 116.1 (d) 114.5 (d)
6 143.3 (s) 144.0 (s) 119.8 (d) 131.2 (d) 131.3 (d) 131.4 (d)
7 118.3 (d) 117.2 (d) 143.1 (s) 123.0 (d) 123.0 (d) 123.6 (d)
8 162.3 (d) 126.9 (d) 117.2 (d) 124.0 (d) 124.1 (d) 126.8 (d)
8a 115.6 (s) 120.4 (s) 121.5 (s) 121.5 (s) 121.6 (s) 122.1 (s)
9 178.2 (s) 180.8 (s) 181.1 (s) 177.2 (s) 178.3 (s) 181.6 (s)
9a 104.7 (s) 108.2 (s) 108.1 (s) 114.9 (s) 114.9 (s) 116.2 (s)
OMe 57.5 (q) 56.4 (q) 60.9 (q) 62.8 (q) - -
59.3 (q) - - - - -
61.9 (q) - - - - -
N-Me - - 34.3 (q) 30.5 (q) 31.5 (q) 31.7 (q)
2’ - - - 73.4 (s) 73.4 (s) 72.3 (s)
2’Me - - - 24.4 (q) 25.0 (q) 24.7 (q)
26.1 (q) 26.2 (q) 26.0 (q)
3’ - - - 28.1 (t) 28.2 (t) 28.1 (t)
4’ - - - 79.6 (d) 78.6 (d) 92.3 (d)
*The multiplicity of the signals obtained by DEPT 135.data, [5,30,33,34] supported that 1 is a 3-hydroxy-1,5,
6-trimethoxy-9-acridone.
Compound 2 exhibited UV and IR signals as in case of
1. Its HRMS showed [M]+ at m/z 257.0681 confirming
C14H11O4N as its molecular formula. Its
1H NMR (Table 1)
spectrum showed singlets at δ 12.12 and δ 8.90 for C-
1-OH and C-6-OH, respectively, along with a relatively
strong upfield singlet at δ 3.93 suggesting the presence
of a methoxy group at C-3 in the acridone skeleton
which was supported by the typical quartet at δ 56.4 in its
13C NMR spectrum. The 13C NMR spectrum (Table 2)
further showed three downfield signals at δ 161.2,
162.4 and 144.0 suggesting 3 oxygenated carbons in A
and C rings of acridone skeleton. The 1H NMR spectrum
exhibited meta coupled doublets (J = 3.0 Hz) at δ 6.58 and
6.44 showing matching substitution in A ring as in case
of compound 1. The typical downfield doublet at δ
7.89 (J = 8.0 Hz) for H-8 in 1H NMR spectrum showed
correlation with a double doublet (J = 8.0, 3.0 Hz) for
H-7 at δ 7.07 which in turn correlated with the doublet
(J = 3.0 Hz) for H-5 at δ 7.39 in its 1H1H COSY. These
data suggested that the second hydroxyl group is attached
at C-6. The relatively upfield shift of C-4 at δ 90.7 in 13C
NMR spectrum for aromatic carbon has been observed in
earlier study [5]. The rest of 13C NMR values (Experimental)
accorded well with the structure for 2 as 1,6-dihydroxy-3-
methoxy-9-acridone.
Compound 3 had the UV and IR bands for acridone
alkaloids as described in the case of 1. Its HRMS showed
[M]+ at m/z 303.0734 corresponding to C15H13O6N. Its
1H NMR spectrum showed four downfield singlets at δ
9.05, 9.32, 9.00 and 8.92 for phenolic protons. The down-
field meta coupled doublet (J = 3.0 Hz) at δ 7.82 typical for
H-8 in its 1H NMR spectrum, clearly suggested that the
doublet (J = 3.0 Hz) at δ 7.20 corresponds to H-6. Its 1H
NMR spectrum showed a typical downfield singlet at δ 4.44
for OMe at C-1 and δ 3.90 for N-Me which was supported
by the quartets in 13C NMR spectrum at δ 60.9 and 34.3,
respectively. A singlet at δ 6.12 in the 1H NMR spectrum
further suggested that rest of the 3 carbons in A ring along
with 2 in C ring are oxygenated which was strengthened by
the presence of a total of five C-O-R signals in its 13C NMR
spectrum at δ 160.0, 161.3, 130.2, 146.2 and 143.1 for C-1,
C-3, C-4, C-5 and C-7, respectively. The relatively strong
upfield shift of C-4 at δ 130.2 for oxygenated carbon with
N-10 methylated acridones fits well with the published data
[5]. These data (Tables 1 and 2) established that 3 is 3,4,5,
7-tetrahydroxy-1-methoxy-10-methyl-9-acridone.
Compound 8 showed UV and IR spectral values for
acridone skeleton as described in the case of 1. Its
HRMS showed [M]+ at m/z 355.1416 for C20H21O5N.
An OH (H-bonded) singlet appeared at δ 15.05 in its 1H
NMR spectrum (Table 1) indicating the presence of a
phenol at C-1. In its 1H NMR spectrum, two sets of
Table 3 In vitro antibacterial activity of extracts of
Z. leprieurii, Z. zanthoxyloides and acridone alkaloids
MIC expressed in μg/mL
Compounds BS ML PA SA
1 >500 >500 500 >500
3 nt 125 125 nt
4 250 125 >500 250
7 250 500 >500 500
8 nt >500 250 nt
10 nt >500 250 nt
Kanamycin 0.53 4.16 62.5 6.94
Extracts
Z. leprieurii >1000 250 1000 >1000
Z. zanthoxyloides >1000 500 >1000 >1000
Gram-positive bacteria: BS = Bacillus subtilis MTCC121, ML =Micrococcus luteus
MTCC2470 and SA = Staphylococcus aureus MTCC96, Gram-negative bacteria:
PA = Pseudomonas aeruginosa MTCC741, nt = not tested. Kanamycin is the
standard antibiotic.
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7.40 for H-8 and H-5 along with two sets of triple dou-
blets (J = 8.0, 8.0, 3.0 Hz) at δ 7.61 and 7.29 for H-6 and
H-7, were available. These signals showed respective cor-
relations from H-5 to H-8 in the 1H1H COSY spectrum
(Experimental) revealing that C ring is unsubstituted at
C-5 to C-8 positions. This fact was justified by the dou-
blets at δ 115.0, 131.2, 123.0 and 124.0 available in its
13C NMR spectrum (Table 2). Since no signals, other
than these four for C ring, were seen in the typically
unsubstituted aromatic region in 1H NMR spectrum of
8, it was concluded that all the four free carbons in A
ring were substituted. The downfield signals at δ 162.1,
166.5 and 123.0 in its 13C NMR spectrum implied that 3
carbons in A ring are oxygenated while 4th carbon is
C-substituted. The relatively strong upfield shift of C-4
at δ 123.0 for oxygenated carbon with N-10 methylated
acridones concurred well with previous report [5]. A set
of additional signals in its 1H NMR spectrum at δ 3.50
(dd, J = 10, 3.5 Hz), δ 2.72 and 3.07 (dd each, J = 13.0,
10.0 Hz) and two methyl singlets (6H) at δ 1.30 designated
the presence of a three carbon chain attached with A ring.
The 1H1H COSY experiment showed a cyclic ring of -CH
(OH)CH2C(O)(CH3)2- attached at C-2 and C-3. Although
the oxidation at C-3 is biogenetically preferred in this class
of compounds, the HMBC experiment established that
C-2 is C-substituted while C-3 is O-substituted. In
HMBC spectrum, the signal for 4’-H at δ 3.50 showed
strong correlation with C-2 at δ 118.2. This type of
cyclization is justified by the 13C NMR values at δ 79.6
(d), 28.1 (t), 73.4 (s) as well as 24.4 and 26.1 (q) along with
C-2 and C-3 singlets at δ 118.2 and 166.5, respectively. In
the NOESY spectrum of 8, the C-4’-H at δ 3.50 showed
a weak correlation with phenolic proton at C-1 at δ 15.05
and no correlation with C-2’-Me, suggesting that OH
at C-4’ is β-oriented. The molecular model of 8 further
reinforced this statement. Its HMQC and HMBC spectra
also supported these observations (Experimental). The 3,
4-cyclization is normally preferred for a more stable
linear structure of acridones. Recently, the linear tetra-
cyclic acridones were reported from Glycosmis parva
by Chansriniyom, et al. [25] having a double bond in
pyran ring. Moreover, similar cyclization product was
earlier reported from the synthesis of 1-hydroxy-1,2-
dihydroisoacronycine by Magiatis et al. [35] but without
oxidation at C-4. Acetylation of 8 yielded 8a showing the
downfield shifting of CH(OH) from δ 3.50 to δ 4.34 along
with an additional signal at δ 2.10 for OAc in its 1H NMR
spectrum. This observation clearly supported the presence
of a CHOH group in this ring. Since the OMe appeared
slightly upfield at δ 3.98 in 1H NMR, it was placed at C-4
and not at C-1, obviously indicating that C-1 is substituted
by a hydroxy group. The typical signals at δ 3.77 (s) in 1H
NMR and δ 30.5 (quartet) in 13C NMR spectra justifiedthe presence of N-Me. The present tetracyclic skeleton
was, tentatively, named as zanthacridone and the data
described as above supported the structure of 8 as
4-methoxyzanthacridone.
Compound 9 had almost similar spectral data except
the methoxy signal in 1H NMR and 13C NMR spectra
(Tables 1 and 2) which clearly suggested that C-4 is now
substituted with a hydroxy group rather than a methoxy, as
was in case of compound 8. In its HRMS, [M]+ appeared at
m/z 341.1257 for C19H19O5N. Therefore, the structure of 9
was assigned as 4-hydroxyzanthacridone.
Compound 10 showed almost similar spectral data as 9
with the following exceptions: In its 1H NMR spectrum,
the CHOH appeared downfield at δ 4.85, as compared to
9 at δ 3.63; the -CH(OH)- also appeared more downfield
at δ 92.3 in 10 than at δ 78.6 in compound 9 in its 13C
NMR spectrum. Moreover, a downfield shift was observed
for C-2 from 117.5 in 9 to 160.2 in 10 in the 13C NMR
spectrum. The relatively strong upfield shift of C-4 at
δ 131.2 for oxygenated carbon with N-10 methylated
acridones, was also in accordance with earlier studies
[5]. Acetylation of 10 gave a downfield shift of CHOH
from δ 4.85 to δ 5.35 with an additional singlet for
OAc at δ 2.11 in 1H NMR spectrum. In the NOESY
spectrum, one of the C-2’-Me at δ 1.32 correlated with
C-4OH at δ 9.10 evidencing that there is no change in the
position of the additional ring and happens to be quite simi-
lar as in case of 8 and 9. Since H-4’ did not correlate with
C-1 in its HMBC spectrum (as was in cases of 8 and 9), it
was evident that there is an extra bond formation by an
oxide between C-2 and C-4’. This observation fits well with
the value of C-2 at δ 160.2 in its 13C NMR spectrum. The
C-4’-OH had a β-orientation as in its NOESY spectrum
H-4’ showed correlation with C-1-OH (Experimental)
AB
Figure 2 Molecular docking of active acridone alkaloids against
(A) anticancer target protein aromatase in human (compounds
1, 8, 9 and 10) and (B) antibacterial WAAG protein of bacteria
(compounds 1, 2, 3, 4, 9 and 10).
Wouatsa et al. Chemistry Central Journal 2013, 7:125 Page 6 of 15
http://journal.chemistrycentral.com/content/7/1/125similar to 8 and 9. In its HRMS, it showed [M]+ at m/z
357.1210 for C19H19O6N. These data clearly supported the
structure of 10 as 4-hydroxyzanthacridone oxide (2,4’).
Biological evaluation
In vitro antibacterial evaluation
The results of the antibacterial activity of the isolated
major acridones (1, 3, 4, 7, 8 and 10) against three Gram-
positive and one Gram-negative bacteria are given in
Table 3. Compound 3 exhibited moderate activity (MIC
125 μg/mL) when tested against Gram-positive Micrococ-
cus luteus and Gram-negative Pseudomonas aeruginosa
whereas 1, 8 and 10 showed activity against P. aeruginosa
with MIC values of 500, 250 and 250 μg/mL, respectively.
Compound 7 had MIC values of 500 and 250 μg/mL
against Staphylococcus aureus and Bacillus subtilis, re-
spectively (Table 3) while 4 displayed a MIC of 250 μg/mL
against both bacteria. Against M. luteus, compounds 4
and 7 demonstrated a moderate activity with MIC 125
and 500 μg/mL, respectively but failed to show appre-
ciable activity against P. aeruginosa. The present study re-
lated the antimicrobial activity with acridone alkaloids
from the genus Zanthoxylum, although the acridones
from the genus Boronea have exhibited this activity, earlier
[36].
Pharmacophore modeling and molecular docking studies
against Glycosyltransferase (WAAG)
Since compounds 3 and 4 showed a MIC of 125 μg/mL
against M. luteus, we carried out a quantitative SAR and
molecular docking to explore the possible mechanism of
action for the observed biological activities targeting gly-
cosyltransferase. Results of pharmacophore modeling
showed that compounds 1, 2, 3, 4, 9 and 10 have signifi-
cant activity against M. luteus. Molecular docking study
of these compounds against WAAG protein, a glycosyl-
transferase involved in lipopolysaccharide biosynthesis
(PDB ID: 2IW1) [37], revealed active conformation and
interacting binding site amino acid residues (Figure 2).
For validation of molecular docking co-crystallised uri-
dine derivative was re-docked on bacterial protein
WAAG (PDB: 2IW1) (Table 4). Compounds 3 and 4
were experimentally validated to be significantly active
against M. luteus. Quantitative SAR studies showed that
compounds 2 and 9 seem to be significantly active
against M. luteus. However, experimentally non-active
compounds 7 and 8 also predicted inactive against M.
luteus. Moreover, compounds 1 and 10 were also pre-
dicted to be inactive against M. luteus (Table 5).
In vitro cytotoxicity evaluation
We screened compounds 1, 4, 7 and 8 for their in vitro
cytotoxicity (Table 6) against liver (WRL-68), colon(CaCO2), breast (MCF-7) and prostate (PC-3) cancer cell
lines using the MTT assay. We found that compounds 4
and 7 failed to produce a significant activity against the
tested human cancer cell lines. However, a previous study
[5] has reported 7 having a moderate antiproliferative ac-
tivity against lung carcinoma and colorectal adenocarcin-
oma cell lines indicating that 7 possesses a selective
cytotoxic activity. Compound 1 showed a moderate activ-
ity (IC50 of 86 μM) against WRL-68; both 1 and 8
exhibited a poor activity against MCF-7 with IC50 229 and
205 μM, respectively.
Table 4 Results of molecular docking experiments targeting antibacterial protein WAAG
Molecule H-
bonds
Bound amino acid residues of WAAG Binding affinity
(kcal/mol)
16 ASP-19, ILE-285, GLY-284, LYS-209, ALA-283, GLU-281,




03 ARG-173, LYS-209, ARG-261 -8.6
Compound 1
02 ARG-173, GLY-289 -8.5
Compound 2
06 PHE-13, ALA-99, SER-204, GLY-284, ILE-285, -7.6
Compound 3
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Table 4 Results of molecular docking experiments targeting antibacterial protein WAAG (Continued)
01 PHE-13 -7.0
Compound 4




03 GLY-15, GLY-281, ILE-285 -8.1
Compound 10
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against aromatase and quinone Reductase
Results of pharmacophore modeling showed that
compounds 1, 8, 9 and 10 have significant activity
against human anticancer target aromatase [38]. Mo-
lecular docking on human aromatase, quinone re-
ductase, not on helicase [39], was preferred because
it is the popular enzyme in vertebrates known to
catalyse the biosynthesis of all oestrogens from an-
drogens and is therefore considered as a frontline
therapy for oestrogen-dependent breast cancer [38].
Molecular docking study of studied compounds (1,
8, 9, 10) against anticancer targets aromatase (PDB:
3EQM), quinone reductase (PDB: 3G5M) showed ac-
tive conformations comparable to control molecule.
During docking experiments interacting binding site
amino acids were namely, LEU-103, TYR-104, SER-
107, GLY-149 for compound 1 with docking energy -6.1 kcal/mol and four H-bonds. Similarly, THR-148,
TYR-155, SER-164 residues were identified for com-
pound 8 with docking energy -6.7 kcal/mol and four
H-bonds. Likewise residues PHE-106, THR-147,
THR-148, TYR-155, SER-164 were identified in the
binding site for compound 9 with docking energy -7
.3 kcal/mol and showed six H-bonds. Compound 10
showed interaction with LEU-103, PHE-106, THR-147
with docking energy -7.7 kcal/mol and three H-bonds
(Table 7, Figure 2). All compounds (1, 8, 9, 10) showed
strong binding affinity with aromatase when compared with
control molecule. Control experiment showed binding site
residues namely, PHE-17, THR-147 with docking energy -5
.8 kcal/mol and two H-bonds. For validation of docking ex-
periment, co-crystallised inhibitor 6-methoxy-9-methyl[1,3]
dioxolo[4,5-h]quinolin-8(9 h)-one was used as control
molecule targeting anticancer protein aromatase (PDB:
3EQM), quinone reductase (PDB: 3G5M) (Table 7).
Table 5 Derived pharmacophore model for antibacterial activity of acridones against M. luteus
Acridones Score obtained Categorizing through
threshold (S = 4.1466)




1. 4.668387 >4.1466 significantly active >500 Non active
2. 4.655514 >4.1466 significantly active Not tested Not tested
3. 4.409138 >4.1466 significantly active 125 Active
4. 5.006913 >4.1466 significantly active 125 Active
5. 3.892896 <4.1466 Non-significant activity Not tested Not tested
6. 4.049106 <4.1466 Non-significant activity Not tested Not tested
7. 2.944231 <4.1466 Non-significant activity 500 Less active
8. 4.008224 <4.1466 Non-significant activity >500 Non active
9. 4.189883 >4.1466 significantly active Not tested Not tested
10. 4.479721 >4.1466 significantly active >500 Not active
The threshold score (S) of 4.1466 has been selected for the screening of lead compounds.
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http://journal.chemistrycentral.com/content/7/1/125Compounds 1 and 8 were experimentally validated to be
significantly active against MCF-7 human breast cancer
cell line. Results showed that out of ten compounds four
showed significant anticancer activity against MCF-7
(Table 8). Besides, all studied compounds showed compli-
ance with Lipinski's rule of five parameters for drug like-
ness and oral bioavailability (Table 9).
Experimental
General experimental procedures
1H and 13C NMR spectra were obtained with a FT-NMR
300 MHz equipped with a 5 mm 1H and 13C (ATP)
probe operating at 300 and 75 MHz, respectively, with
TMS as internal standard. Chemical shifts were reported
in δ (ppm) and coupling constants (J) were measured in
Hz. QTOF-HRMS spectra were recorded on Agilent
6520-QTOF LC/MS having an ESI source in positive
mode. Dry Nitrogen was used with 11 LPM flow rate for
ionization at 350 Dc. The ESIMS was recorded on API-
3000 LC-MS/MS ABSCIEX in 1.0 ppm solution through
MS grade acetonitrile-water with injection mode: infu-
sion through motor driven hardware syringe. UV ana-
lysis was carried out on a Spectronic Genesys 2
spectrophotometer and IR was recorded with FT-IR
Perkin Elmer instrument. Optical rotations were takenTable 6 In vitro cytotoxicity of acridone 1, 4, 7 and 8
IC50 expressed in μM
Compounds WRL-68 CaCO2 MCF-7 PC-3
1 86 >300 229 272
4 >300 >300 >300 >300
7 >300 >300 >300 >300
8 >300 >300 205 >300
Doxorubicin 1.4 6.0 3.6 8.6
WRL-68 = Liver cancer cell lines, CaCO2 = colon cancer, MCF-7 = breast cancer,
PC-3 = prostate cancer. Doxorubicin Sigma D-1515 is the standard used.with a Horiba SEPA-300 polarimeter. Melting points
were determined on a Fisher-Johns melting point appar-
atus and were uncorrected. Precoated aluminium sheets
silica gel 60 F254 TLC plates were used to check the
purity of compounds and preparative TLC was
performed on glass plates of silica gel 60 (20×20 cm,
Merck). Flash chromatography was performed with a
Buchi Pump manager C-615 flash model operating with
two pump modules C-605. Spots were viewed under UV
lamp (254 nm and 365 nm) or sprayed with
Anisaldehyde- sulfuric acid and Draggendorff reagents.
All reagents used, were of analytical grades.
Plant material
The dried fruits of Z. leprieurii and Z. zanthoxyloides
were collected at Douala, Littoral Province of Cameroon
in December 2009. The plants were identified at the
University of Douala (TF) and the samples were com-
pared with the voucher specimen number 2713/SRFK/
CAM and 21793/SFR/CAM for Z. leprieurii and Z.
zanthoxyloides, respectively at the National Herbarium
of Cameroon, Yaounde.
Extraction and isolation
Extraction and isolation from Z. zanthoxyloides
The dried and ground fruits (400 g) were successively
extracted under percolation at room temperature over-
night with n-hexane three times. Thereafter, they were
extracted by methanol at room temperature overnight
which gave 16 g of crude extracts. A portion of this
extract (10 g) was dissolved in CHCl3 (30 mL) and
extracted three times with 5 N HCL. The aqueous layer
was basified with 25% ammonium hydroxide and the basic
alkaloidal part was extracted with CHCl3 (3×100 mL). The
extract was dried over anhydrous sodium sulfate and
solvent was evaporated. The extract (240 mg) obtained as
above, after silica gel column chromatography (58 g,
Table 7 Results of molecular docking experiments targeting anticancer protein uinine reductase (PDB: 3G5M) and
aromatase (PDB: 3EQM)
Molecule H-bonds Bound amino acid residues Binding affinity (kcal/mol)
2 ASP-309, MET-374 -9.5
Androstenedione (control inhibitor)
02 PHE-17, THR-147 -5.8
6-methoxy-9-methyl[1,3]dioxolo[4,
5-h]quinolin- 8(9 h)-one (Control inhibitor)
04 LEU-103, TYR-104, SER-107, GLY-149 -6.1
Compound 1
04 THR-148, TYR-155, SER-164 -6.7
Compound 8
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Table 7 Results of molecular docking experiments targeting anticancer protein uinine reductase (PDB: 3G5M) and
aromatase (PDB: 3EQM) (Continued)
06 PHE-106, THR-147, THR-148, TYR-155, SER-164 -7.3
Compound 9
03 LEU-103, PHE-106, THR-147 -7.7
Compound 10
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http://journal.chemistrycentral.com/content/7/1/12560-120 mesh, 2.3 × 93 cm) with the mixtures of n-hexane,
EtOAc and MeOH in the increasing order of polarity in
basic medium (2 drops ammonium hydroxide/100 mL
solvent), afforded 16 fractions. From fraction 8, after pre-
parative TLC, 4 (5 mg) was obtained. While fraction 9
(n-hexane-EtOAc, 1:4) was left to crystallize at room
temperature to obtain orange crystals of 3 (3.5 mg, TLC,
EtOAc- CHCl3- MeOH, 97:1:2, Rf 0.24), fraction 10 eluted
with n-hexane-EtOAc (1:4 and 1:9) was further purified
through preparative TLC to afford 2 (6 mg, TLC, MeOH+
1% NH4OH- C6H6- CH2Cl2, 1:2:2, Rf 0.64). Fractions (11-13)
which were complex mixtures were pooled together and
purified through flash chromatography (20 g, 230-400 mesh,
15 × 100 mm glass column C-690 Sepacore Buchi fitted with
a precolumn of ID 15 mm) with EtOAc as solvent A and
MeOH plus 2 drops ammonium hydroxide/100 mL as solv-
ent B. The flow rate was set up to 2.5 mL/min. A total of 52
fractions (each of 12 mL) were collected and pooled
according to their TLC pattern into four fractions. Fractions
1 and 2 gave yellowish crystals of 1 (32 mg, TLC, EtOAc-
MeOH+ 1% NH4OH, 9:1, Rf 0.71), 8 (19.2 mg, TLC,
EtOAc- MeOH+ 1% NH4OH, 9:1, Rf 0.67) and 5. Fraction 3
afforded 9 (10.3 mg, TLC, EtOAc- MeOH+1% NH4OH,
9:1, Rf 0.53) and fraction 4 yielded 10 (22 mg, TLC, EtOAc-
MeOH+ 1% NH4OH 9:1, Rf 0.49). All the isolated alkaloids
gave yellowish orange colored crystals or crystalline yellow
mass and positive test with Dragendorff reagent.Extraction and isolation from Z. leprieurii
The dried fruits (380 g) after extraction as described above,
yielded 48 g of methanol extract from which 40 g was
dissolved in CHCl3 (110 mL) and the alkaloids extracted as
detailed above. The silica gel cc (120 g, 60-120 mesh, 2.5 ×
100 cm) yielded complex mixtures (340 mg) which after
flash chromatography (116 g, 230-400 mesh, 36 × 230 mm
glass column C-690 Sepacore Buchi) using n-Hexane as
solvent A and EtOAc plus 2 drops ammonium hydroxide/
100 mL as solvent B with the flow rate stated as above,
afforded eight fractions. Recrystallisation of fractions 3, 5
and 6 in MeOH- CHCl3 afforded 7 (10 mg), 1 (3 mg) and 4
(40 mg), respectively. Compound 6 (5 mg) was obtained
from fraction 7, after recrystallization in MeOH- CHCl3.
Spectroscopic data of new compounds
3-Hydroxy-1,5,6-trimethoxy-9-acridone (1): Mp: 165°C;
UV (CHCl3) λmax (log ε) nm: 233 (0.781), 252 (2.511),
320 (0.426); IR (KBr) νmax cm
-1: 3448, 2929, 1620, 1579,
1507; 1H and 13C NMR see Tables 1 and 2; 1H1H COSY:
H-8 at δ 7.99 ― H-7 at δ 7.21; HMBC: C-3-OH→C-3,
C-2, C-4; C-5-OMe→C-5; C-6-OMe→C-6; ESIMS m/z
(rel. int.): 301 (5) [M]+, 282 (100), 260 (82), 227 (30), 202
(42); HRMS: 301.0944 (Calc. for C16H15O5N 301.0945).
1,6-Dihydroxy-3-methoxy-9-acridone (2): UV (CHCl3)
λmax (log ε) nm: 251 (2.011), 321 (0.406); IR (KBr) νmax
cm-1: 3438, 2929, 1620, 1579; 1H and 13C NMR see Tables 1
Table 8 Derived pharmacophore model for anticancer activity of acridones active against human cancer cell line MCF-7
Acridones Score obtained Categorizing through threshold
(S = 4.1274)
Predicted activity Experimental activity
(IC50 in μM)
Experimental response
1. 4.2712 > 4.1274 significantly active 229 Poor activity
2. 3.5826 < 4.1274 Non-significant activity Not tested Not tested
3. 3.6316 < 4.1274 Non-significant activity Not tested Not tested
4. 3.6796 < 4.1274 Non-significant activity >300 Non active
5. 3.3015 < 4.1274 Non-significant activity >300 Non active
6. 2.9402 < 4.1274 Non-significant activity Not tested Not tested
7. 2.4587 < 4.1274 Non-significant activity Not tested Not tested
8. 5.1457 > 4.1274 Significantly active 205 Poor activity
9. 4.9482 > 4.1274 Significantly active Not tested Not tested
10. 5.5092 > 4.1274 Significantly active Not tested Not tested
The threshold score (S) of 4.1274 has been selected for the screening of lead compounds.
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C-3-OMe→C-3; ESIMS m/z (rel. int.): 257 (15) [M]+, 245
(60), 214 (100); HRMS: 257.0681 (Calc. for C14H11O4N
257.0683).
3,4,5,7-Tetrahydroxy-1-methoxy-10-methyl-9-acridone
(3): Mp > 250°C; UV (CHCl3) λmax (log ε) nm: 262
(2.511), 320 (0.426); IR (KBr) νmax cm
-1: 3430, 2929,
1620, 1580; 1H and 13C NMR see Tables 1 and 2;
HMBC: C-1-OMe→C-1; H-2→ C-2, C-1, C-3; ESIMS
m/z (rel. int.): 303 (5) [M+], 298 (8), 286 (22), 282 (100);
HRMS: 303.0734 (Calc. for C15H13O6N 303.0737).
4-Methoxyzanthacridone (8): [α]D
22: -3.69o (CHCl3,
c = 0.22); UV (CHCl3) λmax (log ε) nm: 243 (1.898), 275
(1.204), 327 (1.005); IR (KBr) νmax cm
-1: 3368, 2929,
1654, 1620, 1579; 1H and 13C NMR see Tables 1 and 2;
1H1H COSY: H-8 at δ 7.82 ― H-7 at δ 7.29 ― H-6 at δTable 9 Compliance of acridone alkaloids with standard
parameters of Lipinski’s rule of five for drug likeness and
oral bioavailability
Acridone alkaloids miLOGP MW nON nOHNH nviolations
1 1.926 301.298 6 2 0
2 1.862 257.245 5 3 0
3 1.119 303.27 7 4 0
4 2.189 285.299 5 1 0
5 2.433 255.273 4 1 0
6 1.913 271.272 5 2 0
7 2.173 255.273 4 1 0
8 2.476 355.39 6 2 0
9 2.2 341.363 6 3 0
10 2.411 357.362 7 3 0
miLogP = octanol/water partition coefficient, MW =molecular weight, nON =
number of hydrogen acceptor, nOHNH = number of hydrogen donor,
nviolations = violations from Lipinski’s rule.7.61 ― H-5 at δ 7.40; H-4’ at δ 3.50 ― H-3a’ at δ 2.72
― H-3b’ at δ 3.07; HMBC: H-4’ à C-2, C-1, C-2’, C-3’;
H-3a’ and H-3b’à C-2, C-4’, C-2’; C-2’Me àC-2’, C-3’;
NOESY: H4’― C-1-OH, H-3’a, H-3’b; ESIMS m/z (rel.
int.): 355 (2) [M]+, 330 (18), 314 (100), 202 (8); HRMS:
355.1416 (Calc. for C20H21O5N 355.1414).
Acetylation of 4-methoxyzanthacridone (8)
Using 1 mL of acetic anhydride and one drop of pyri-
dine, 8 (2 mg) was acetylated and left for reflux at ambi-
ent temperature for 6 hrs. The reaction mixture after
solvent evaporation under rotavapor yielded compound
8a. 1H NMR (CDCl3, δ): 4.34 (dd, J = 10.0, 3.5 Hz) H4’,
2.10, s, OAc.
4-Hydroxyzanthacridone (9): [α]D
22: -4.11o (CHCl3, c =
0.11); UV (CHCl3) λmax (log ε) nm: 243 (1.826), 318
(0.618), 329 (0.562); IR (KBr) νmax cm
-1: 3360, 2931,
1652, 1620, 1581; 1H and 13C NMR see Tables 1 and 2;
1H1H COSY: H-8 at δ 8.40 ― H-7 at δ 7.34 ― H-6 at
δ 7.59 ― H-5 at δ 7.41; H-4’ at δ 3.63 ― H-3a’ at δ
2.68 ― H-3b’ ― at δ 3.00; HMBC: H-4’→ C-2, C-1,
C-2’, C-3’; H-3a’and H-3b’→ C-2, C-4’, C-2’; C-2’Me→
C-2’, C-3’; NOESY: H-4’—C-1-OH, H-3’a, H-3’b;
ESIMS m/z (rel. int.): 341 (2) [M]+, 296 (32), 282
(100), 260 (35), 224 (40); HRMS: 341.1257 (Calc. for
C19H19O5N 341.1258).
Acetylation of 4-hydroxyzanthacridone (9)
Using 1 mL of acetic anhydride and one drop of pyridine, 9
(2 mg) was acetylated and left for reflux at ambient
temperature for 6 hrs. The reaction mixture after solvent
evaporation under rotavapor yielded compound 9a. 1H NMR
(CDCl3, δ): 4.22 (dd, J = 10.0, 3.5 Hz) H-4’, 2.10, s, OAc.
4-Hydroxyzanthacridone oxide (2,4’) (10): [α]D
22:
-1.32o (CHCl3, c = 0.25); UV (CHCl3) λmax (log ε) nm:
242 (1.247), 312 (0.507); IR (KBr) νmax cm
-1: 3423, 1654,
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COSY: H-8 at δ 8.39 ― H-7 at δ 7.34 ― H-6 at δ 7.55 ―
H-5 at δ 7.34; H-4’ at δ 4.85 ― H-3a’ at
δ 3.23 and H-3b’ at δ 3.25; HMBC: H4’→C-2, C-2’, C-3’;
H-3a’and H-3b’→C-4’, C-2’; C-2’Me→C-2’, C-3’; NOESY:
H-4’― C-1-OH, H-3’a, H-3’b; C-2’Me— C-4OH; ESIMS
m/z (rel. int.): 357 (2) [M]+, 316 (28), 296 (72), 282 (100),
260 (48); HRMS: 357.1210 (Calc. for C19H19O6N 357.1207).
Acetylation of 4-hydroxyzanthacridone oxide (2,4’) (10)
Acetylation was done on 2 mg of 10 using 1 mL of acetic
anhydride and one drop of pyridine and left for reflux at
ambient temperature for 6 hrs. The reaction mixture after
solvent evaporation under rotavapor yielded compound




The four bacterial strains viz., Micrococcus luteus
MTCC2470, Staphylococcus aureus MTCC96, Bacillus
subtilis MTCC121 and Pseudomonas aeruginosa
MTCC741 used for the assay, were acquired from Micro-
bial Type Culture Collection (MTCC), Chandigarh, India.
MIC values of the tested compounds 1, 3, 4, 7, 8 and 10
against pathogens, were determined by microdilution
method [40]. The inocula of microorganisms were prepared
from a 17 h broth culture and the suspensions were ad-
justed to 0.5 Mc Farland turbidity. The tested samples were
first dissolved in dimethyl sulfoxide (DMSO), then in
Mueller Hinton Broth to the highest dilution of 500 μg/
mL. Then, serial twofold dilutions were made in a series of
concentration with 0.0078 μg/mL being the smallest con-
centration in the 96 wells microplate. Ampicillin and Kana-
mycin diluted prior in water were used as reference
antibiotics. Negative control was made with DMSO.
Cytotoxicity assay
IC50 values for compounds 1, 4, 7 and 8 were determined
as described previously [41]. 1.5-2.0X103 cells/well were in-
cubated in the 5% CO2 incubator for 24 h to enable them
to adhere properly to the 96-well microplates (Greiner,
Germany). Test compounds dissolved in DMSO were
added at varying concentrations and left for 4 h. After
48 h, 10 μL MTT (Sigma M-2128) was added and the
plates were incubated for an additional 4 h. The absorb-
ance was read on a Fluostar Omega Microplate reader
(BMG LABTECH, Australia) at 570 nm within 1 h of
DMSO addition and the respective IC50 were calculated.
The experiments were done in triplicate.
Molecular modeling and docking studies
A pharmacophore model has been derived to predict the
cytotoxic and antibacterial activities of acridone alkaloidsagainst human cancer cell line MCF-7 and M. luteus, re-
spectively. Derived QSAR models have been validated
using standard method [42]. For QSAR model develop-
ment against MCF-7, a total of 27 known compounds were
used in the training data set. These compounds showed
>70% structural similarity with acridone alkaloid skel-
eton. For statistical relationship eight chemical descrip-
tors namely, AlogP, BCUTw-1 l, Eccentric connectivity
index, LipoaffinityIndex, McGowan volume, Petitigen
number, TPSA and Zagreb index were calculated for
QSAR model building. The similar approach has been
used for the development of QSAR model for antibac-
terial activity. On the other hand, molecular docking
simulation study was performed by AutoDock-Vina soft-
ware [43]. Aromatase (PDB:3EQM), quinone reductase
(PDB: 3G5M) and glycosyltransferase (WAAG) (PDB:
2IW1) target proteins have been used during docking ex-
periments to reveal the binding affinity against anticancer
and antibacterial targets, respectively [37,44]. Drug likeness
and oral bioavailability of studied compounds were evalu-
ated through Lipinski’s rule of five.
Conclusions
Although acridone class of alkaloids are uncommon in
nature but they have been found to be present in sev-
eral Genus of Family Rutaceae. Only one specy of
Zanthoxylum, i.e. Z. leprieurii, has recently been inves-
tigated for acridone alkaloids, in detail. Now, we have
investigated the fruits of medicinally important species
of Cameroonian Z. zanthoxyloides and Z. leprieurii,
for their acridone alkaloids and confirmed their anti-
bacterial and cytotoxic activities. The prediction of
possible mechanism of action has been done through
molecular modeling of the isolated compounds. More-
over, the present work of isolation of novel acridone alka-
loids from Z. zanthoxyloides emphasizes their uniqueness
as taxonomic markers among the African species of this
genus. We have isolated and identified 10 acridones out of
which 6 were new (1, 2, 3, 8, 9 and 10). Acridones 8, 9 and
10 are described with an unusual tetracyclic acridone
which has now been named as zanthacridone because of
their new carbon skeleton. The quantitative SAR and mo-
lecular modeling studies suggested that the compounds 1,
9 and 10 are inhibitors of aromatase, quinone reductase
and glycosyltransferase. Therefore, these compounds hold
the promise for further studies to use them as chemopre-
ventive agents and LPS inhibitors.
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